PRKAA1 and fatty liver disease: AMPK-SIRT1 activation by SGE was found to regulate cellular pathological signaling for liver and adipocyte dysmetabolism, mitigating liver steatosis and adipocyte metabolic issues while addressing ER and mitochondrial redox-linked disorders [66].